Resource Hub

For more on the resources IPAC provides and links to external information please read more below.

IPAC Publications and Case Studies

IPAC / IPAC-RS Final Submission to ECHA REACH Proposal on PFAS (September 2023)

IPAC / IPAC-RS Preliminary Submission to ECHA REACH Proposal on PFAS (May 2023)

IPAC / IPAC-RS Joint Submission to Health Canada Report and Risk Management Scope on PFAS

IPAC Core Messaging

IPAC Letter to European Commission Officials

IPAC Member Survey on European Manufacture and Export of HFC MDIs

In 4Q 2021, the International Pharmaceutical Aerosol Consortium (IPAC) conducted a survey of its member companies regarding the manufacture of HFC MDIs in the European Union, including volumes imported and exported. This document summarizes the compiled, aggregate survey responses from IPAC members. All data refers to calendar year 2020.

Multi-Stakeholder Approach to Minimizing the Environmental Impact of Inhaled Therapies and Improving Patient Care

On 5 May 2021, IPAC presented this work at the Respiratory Drug Delivery conference. The paper provides context on the evolving global legislative and regulatory landscape relevant to medical propellants and shares IPAC’s views on the most effective holistic, patient-care approach to the global environmental challenges of inhaled therapies.

European Respiratory Society (ERS) Panel on Asthma and Climate Change

In May 2021, IPAC joined clinicians, policymakers, and patients in a live panel discussion organized by European Respiratory Society to consider the implications of climate change for asthma patients and shared perspectives on ways to achieve environmental progress and optimize patient care.

IPAC-RS was formed as part of the International Pharmaceutical Aerosol Consortium (IPAC) in 1999 and established in 2001 as a separate Consortium, with the mission to enhance the quality and availability to patients of orally inhaled and nasal drug products (OINDP) through scientifically driven advancements related to development and regulation of these products.

External Resources and Information

The Montreal Protocol

The Ozone Secretariat

Asthma and Lung UK